Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Obstet Gynecol. 2014 Sep 30;212(3):365.e1–365.e7. doi: 10.1016/j.ajog.2014.09.032

Table 3.

Postpartum clinical and laboratory results among mothers with HBV follow-up after delivery

Variable N=137
Time from HBV diagnosis to HBV follow-up, median months (IQR) 12.0 (59.3)
Yearly adherence, n (%)
 ALT monitoring 60 (44%)
 HBV DNA monitoring 29 (21%)
 HCC screening
  AFP 27 (20%)
  Abdominal imaging 34 (25%)
Antiviral therapy at any time, n (%) 29 (21%)
 Tenofovir 17/29 (59%)
 Entecavir 7/29 (24%)
 Lamivudine 4/29 (14%)
 Interferon 1/29 (3%)